Gastric Cancer, Version 3.2016

被引：720

作者：

Ajani, Jaffer A. ^{[1
]}

D'Amico, Thomas A. ^{[2
]}

Almhanna, Khaldoun ^{[3
]}

Bentrem, David J. ^{[4
]}

Chao, Joseph ^{[5
]}

Das, Prajnan ^{[1
]}

Denlinger, Crystal S. ^{[6
]}

Fanta, Paul ^{[7
]}

Farjah, Farhood ^{[8
]}

Fuchs, Charles S. ^{[9
]}

Gerdes, Hans ^{[10
]}

Gibson, Michael ^{[11
,12
]}

Glasgow, Robert E. ^{[13
]}

Hayman, James A. ^{[14
]}

Hochwald, Steven ^{[15
]}

Hofstetter, Wayne L. ^{[1
]}

Ilson, David H. ^{[10
]}

Jaroszewski, Dawn ^{[16
]}

Johung, Kimberly L. ^{[17
]}

Keswani, Rajesh N. ^{[4
]}

Kleinberg, Lawrence R. ^{[18
]}

Korn, W. Michael ^{[19
]}

Leong, Stephen ^{[20
]}

Linn, Catherine ^{[21
]}

Lockhart, A. Craig ^{[22
,23
]}

Ly, Quan P. ^{[24
]}

Mulcahy, Mary F. ^{[4
]}

Orringer, Mark B. ^{[14
]}

Perry, Kyle A. ^{[25
,26
]}

Poultsides, George A. ^{[27
]}

Scott, Walter J. ^{[6
]}

Strong, Vivian E. ^{[10
]}

Washington, Mary Kay ^{[21
]}

Weksler, Benny ^{[28
]}

Willett, Christopher G.

Wright, Cameron D. ^{[29
]}

Zelman, Debra ^{[30
]}

McMillian, Nicole

Sundar, Hema

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Duke Canc Inst, Durham, NC USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[5] City Hope Comprehens Canc Ctr, Duarte, CA USA

[6] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[7] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[8] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Seattle, WA USA

[9] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[10] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[11] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[12] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA

[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[14] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[15] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[16] Mayo Clin, Ctr Canc, Rochester, MN USA

[17] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[18] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[19] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[20] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[21] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[22] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[23] Washington Univ, Sch Med, St Louis, MO 63130 USA

[24] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[25] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[26] Solove Res Inst, Columbus, OH USA

[27] Stanford Canc Inst, Stanford, CA USA

[28] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA

[29] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[30] Debbies Dream Fdn Curing Stomach Canc, Plantation, FL USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 10期

关键词：

RANDOMIZED PHASE-III; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA; S-1 PLUS CISPLATIN; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; HIGH-DOSE METHOTREXATE; SUPPORTIVE CARE; COMBINATION CHEMOTHERAPY; EMISSION-TOMOGRAPHY; GENE AMPLIFICATION; 1ST-LINE THERAPY;

D O I：

10.6004/jnccn.2016.0137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Gastric cancer is the fifth most frequently diagnosed cancer and the third leading cause of death from cancer in the world. Several advances have been made in the staging procedures, imaging techniques, and treatment approaches. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer provide an evidence- and consensus-based treatment approach for the management of patients with gastric cancer. This manuscript discusses the recommendations outlined in the NCCN Guidelines for staging, assessment of HER2 overexpression, systemic therapy for locally advanced or metastatic disease, and best supportive care for the prevention and management of symptoms due to advanced disease.

引用

页码：1286 / 1312

页数：27

共 114 条

[71]

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients [J].

Louvet, C ;

André, T ;

Tigaud, JM ;

Gamelin, E ;

Douillard, JY ;

Brunet, R ;

François, E ;

Jacob, JH ;

Levoir, D ;

Taamma, A ;

Rougier, P ;

Cvitkovic, E ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) :4543-4548

[72]

A systematic review of methods to palliate malignant gastric outlet obstruction [J].

Ly, Jasen ;

O'Grady, Gregory ;

Mittal, Anubhav ;

Plank, Lindsay ;

Windsor, John A. .

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (02) :290-297

[73]

Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer [J].

Matsumoto, Y ;

Yanai, D ;

Tokiyama, H ;

Nishiaki, M ;

Higaki, S ;

Okita, K .

JOURNAL OF GASTROENTEROLOGY, 2000, 35 (05) :326-331

[74]

FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort [J].

Maugeri-Sacca, Marcello ;

Pizzuti, Laura ;

Sergi, Domenico ;

Barba, Maddalena ;

Belli, Franca ;

Fattoruso, Silvia Ileana ;

Giannarelli, Diana ;

Amodio, Antonella ;

Boggia, Sara ;

Vici, Patrizia ;

Di Lauro, Luigi .

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2013, 32

[75]

Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients [J].

Mezhir, James J. ;

Shah, Manish A. ;

Jacks, Lindsay M. ;

Brennan, Murray F. ;

Coit, Daniel G. ;

Strong, Vivian E. .

ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (12) :3173-3180

[76]

A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction [J].

Moehler, M. ;

Kanzler, S. ;

Geissler, M. ;

Raedle, J. ;

Ebert, M. P. ;

Daum, S. ;

Flieger, D. ;

Seufferlein, T. ;

Galle, P. R. ;

Hoehler, T. .

ANNALS OF ONCOLOGY, 2010, 21 (01) :71-77

[77]

TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

[78]

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer [J].

Okines, A. F. C. ;

Norman, A. R. ;

McCloud, P. ;

Kang, Y. -K. ;

Cunningham, D. .

ANNALS OF ONCOLOGY, 2009, 20 (09) :1529-1534

[79]

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial [J].

Ott, K ;

Fink, U ;

Becker, K ;

Stahl, A ;

Dittler, HJ ;

Busch, R ;

Stein, H ;

Lordick, F ;

Link, T ;

Schwaiger, M ;

Siewert, JR ;

Weber, WA .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4604-4610

[80]

Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer:: Long-term results of a prospective study [J].

Ott, Katja ;

Herrmann, Ken ;

Lordick, Florian ;

Wieder, Hinrich ;

Weber, Wolfgang A. ;

Becker, Karen ;

Buck, Andreas K. ;

Dobritz, Martin ;

Fink, Ulrich ;

Ulm, Kurt ;

Schuster, Tibor ;

Schwaiger, Markus ;

Siewert, Joerg-Ruediger ;

Krause, Bernd J. .

CLINICAL CANCER RESEARCH, 2008, 14 (07) :2012-2018

← 3 4 5 6 7 8 9 10 11 12 →